Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josip A Borovac

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Heart (British Cardiac Society)|May 9, 2020
Lipoprotein(a), a moving target: from the primary to secondary prevention of atherothrombotic eventsJosip A Borovac
Expert Review of Cardiovascular Therapy|February 7, 2022
Early in-hospital initiation and optimization of comprehensive disease-modifying pharmacotherapy in patients with heart failure with reduced ejection fraction: a time for the paradigm shiftJosip A Borovac
Heart (British Cardiac Society)|March 19, 2021
Neurohormones and death in systolic heart failure: keep your friends close, but your enemies closerJosip A Borovac
European Heart Journal. Acute Cardiovascular Care|March 1, 2023
Rapid response to the editor regarding the journal article 'Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy'Josip A Borovac
The American Journal of Cardiology|September 18, 2023
Coronary and Extracoronary Manifestations of Systemic Inflammatory, Autoimmune, and Connective Tissue Diseases: Pathophysiologic Drivers of Vasculopathy Beyond AtherosclerosisJosip A Borovac, Chun Shing Kwok
European Journal of Heart Failure|November 28, 2020
Coronary microvascular dysfunction in heart failure with preserved ejection fraction: not the end but the end of the beginningDomenico D'Amario, Josip A Borovac, Filippo Crea
Proceedings (Baylor University. Medical Center)|August 21, 2024
Breast cancer and heart failure: don't let the statistics get in the way of the factsJosip A Borovac, John G F Cleland
Frontiers in Cardiovascular Medicine|July 1, 2022
Editorial: MINOCA: Pathogenesis, Diagnosis, Clinical Management and Evolution Towards Precision MedicineDomenico D'Amario, Rocco A Montone, Josip A Borovac
Heart, Lung & Circulation|May 25, 2019
Predicting the 1-Year All-Cause Mortality After Hospitalisation for an Acute Heart Failure Event: A Real-World Derivation Cohort for the Development of the S<sub>2</sub>PLiT-UG ScoreJosip A Borovac, Duska Glavas, Josko Bozic, et al.
The American Journal of Cardiology|September 25, 2023
High-Dose Statins in Preventing Microvascular Obstruction: "The Devil Lies in the Details"Renzo Laborante, Emiliano Bianchini, Josip A Borovac, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Heart (British Cardiac Society)|May 9, 2020
Lipoprotein(a), a moving target: from the primary to secondary prevention of atherothrombotic eventsJosip A Borovac
Expert Review of Cardiovascular Therapy|February 7, 2022
Early in-hospital initiation and optimization of comprehensive disease-modifying pharmacotherapy in patients with heart failure with reduced ejection fraction: a time for the paradigm shiftJosip A Borovac
Heart (British Cardiac Society)|March 19, 2021
Neurohormones and death in systolic heart failure: keep your friends close, but your enemies closerJosip A Borovac
European Heart Journal. Acute Cardiovascular Care|March 1, 2023
Rapid response to the editor regarding the journal article 'Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy'Josip A Borovac
The American Journal of Cardiology|September 18, 2023
Coronary and Extracoronary Manifestations of Systemic Inflammatory, Autoimmune, and Connective Tissue Diseases: Pathophysiologic Drivers of Vasculopathy Beyond AtherosclerosisJosip A Borovac, Chun Shing Kwok
European Journal of Heart Failure|November 28, 2020
Coronary microvascular dysfunction in heart failure with preserved ejection fraction: not the end but the end of the beginningDomenico D'Amario, Josip A Borovac, Filippo Crea
Proceedings (Baylor University. Medical Center)|August 21, 2024
Breast cancer and heart failure: don't let the statistics get in the way of the factsJosip A Borovac, John G F Cleland
Frontiers in Cardiovascular Medicine|July 1, 2022
Editorial: MINOCA: Pathogenesis, Diagnosis, Clinical Management and Evolution Towards Precision MedicineDomenico D'Amario, Rocco A Montone, Josip A Borovac
Heart, Lung & Circulation|May 25, 2019
Predicting the 1-Year All-Cause Mortality After Hospitalisation for an Acute Heart Failure Event: A Real-World Derivation Cohort for the Development of the S<sub>2</sub>PLiT-UG ScoreJosip A Borovac, Duska Glavas, Josko Bozic, et al.
The American Journal of Cardiology|September 25, 2023
High-Dose Statins in Preventing Microvascular Obstruction: "The Devil Lies in the Details"Renzo Laborante, Emiliano Bianchini, Josip A Borovac, et al.
Pageof 9